Protective effects of docosahexaenoic acid against non-alcoholic hepatic steatosis through activating of JAK2/STAT3 signaling pathway

文献类型： 外文期刊

第一作者： Wang, Yue

作者： Wang, Yue;Duan, Yinping;Li, Huixia;Li, Huixia;Chen, Kunlin;Quan, Yan

作者机构：

关键词： Docosahexaenoic acid; NAFLD; L02 cell; Lipid accumulation; JAK2/STAT3

期刊名称：BIOCELL （ 影响因子：1.254； 五年影响因子：0.924 ）

ISSN： 0327-9545

年卷期： 2021 年 45 卷 2 期

页码：

收录情况： SCI

摘要： Non-alcoholic fatty liver disease is the most common cause of hepatic dysfunction. In the present study, human normal hepatocyte L02 cells were treated with 50% fetal bovine serum to induce the formation of hepatic steatosis in vitro, and then the cells were treated with docosahexaenoic acid to investigate its protective effect on Non-alcoholic fatty liver disease. Our results showed that 50% of fetal bovine serum significantly induced intracellular lipid accumulation and hepatocyte fatty degeneration within 48 h. The expression level of adipose formation-related genes was significantly up-regulated, such as PPAR gamma, C/EBP alpha and SREBP-1; meanwhile, the content of cellular total lipid, total cholesterol and triglycerides were significantly increased after 50% fetal bovine serum treatment. Interestingly, docosahexaenoic acid treatment could inhibit FBS-induced intracellular lipid accumulation in L02 cells and the expression of lipogenic genes. Moreover, docosahexaenoic acid treatment could reduce hepatic steatosis-induced oxidative stress and endoplasmic reticulum stress response, and these responses were shown by the modification of antioxidant enzyme activities and GRP78, CHOP expression. In addition, the results showed that docosahexaenoic acid can activate the JAK2/STAT3 signaling pathway in fatty liver L02 cell; inhibition of JAK2/STAT3 signaling pathway by WP1066 abolished the beneficial effects of docosahexaenoic acid on hepatic steatosis accompanied with the increased expression of lipogenic genes and endoplasmic reticulum stress response. Above all, the present study showed that docosahexaenoic acid can alleviate non-alcoholic hepatic steatosis by activating JAK2/STAT3 signaling pathway.

分类号：

  • 相关文献
作者其他论文 更多>>

微信小程序